Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04647435
PHASE3

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Sponsor: Apsen Farmaceutica S.A.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy of APSCTC compared to two active drugs in acute pain relief.

Official title: National, Multicentre, Randomized, Double-blind, Triple-dummy Active-Controled Phase III Clinical Trial to Evaluate the Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction.

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

396

Start Date

2023-05-13

Completion Date

2024-10-04

Last Updated

2026-09-04

Healthy Volunteers

Yes

Interventions

DRUG

APSCTC

APSCTC + Toragesic® placebo + Tramal® placebo

DRUG

Toragesic®

APSCTC placebo + Toragesic® + Tramal® placebo

DRUG

Tramal®

APSCTC placebo + Toragesic® placebo + Tramal®

Locations (1)

Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.

Valinhos, São Paulo, Brazil